Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Anal Swab
14%
CagA
14%
Cardiovascular Risk
14%
Celiac Disease
14%
Colonoscopy
18%
Colorectal Cancer
46%
Colorectal Cancer Patients
45%
Consensus Document
15%
Constipation
31%
Constipation Symptoms
28%
Cyclin D1 (CCND1)
14%
Dietary Supplementation
14%
Dyspepsia
28%
Early-onset Colorectal Cancer (EOCRC)
14%
Epidemiological Study
14%
Functional Constipation
57%
Gastric Cancer
18%
Gastroesophageal Reflux Disease
31%
Gastrointestinal Diseases
16%
Gene-gene Interaction
14%
General Hospital
23%
Genotype
14%
Helicobacter Pylori (H. pylori)
31%
Helicobacter Pylori Infection
45%
Indonesia
100%
Indonesian
28%
Indonesian Language
16%
Indonesian Patients
25%
Jakarta
24%
Obscure Gastrointestinal Bleeding
14%
Patient Assessment
25%
Patient Assessment of Constipation Quality of Life
14%
Patient-derived Spheroids
14%
Patients with Colorectal Cancer
21%
Peripheral Blood
14%
Primary Cell Culture
14%
Quality of Life Questionnaire
14%
Quantitative PCR
14%
Questionnaire Reliability
14%
Questionnaire Validity
14%
Randomized Double-blind Controlled Trial
16%
Recombinant Lactobacillus Plantarum
17%
Rheumatoid Arthritis Patients
14%
Risk Factors
30%
Rome IV
14%
Subjective Symptoms
14%
Symptom Severity
28%
Tumor Microenvironment
28%
Urban Women
28%
Virulence Genes
14%
Medicine and Dentistry
Abdominal Cancer
20%
Argon Plasma Coagulation
14%
Bleeding
12%
Cancer
11%
Cell Culture
14%
Circulating Tumor Cell
14%
Colonoscopy
18%
Colorectal Carcinoma
79%
Constipation
41%
Cyclin D1
14%
Diseases
9%
Endoscopic Biopsy
14%
Endoscopic Hemostasis
14%
Esophageal Stricture
14%
Fenofibrate
11%
Functional Constipation
35%
Gastroesophageal Reflux
16%
Gastrointestinal Bleeding
18%
Gastrointestinal Cancer
14%
Gastrointestinal Endoscopy
21%
Gastrointestinal Infection
14%
Gene Interaction
14%
Helicobacter Infection
30%
Helicobacter Pylori
47%
Indonesian (Language)
16%
Infection
26%
Lactobacillus plantarum
16%
Malignant Neoplasm
22%
Mucosa
14%
Neoplasm
16%
Non-Invasive Diagnostics
14%
Patient Assessment
36%
Placebo
10%
Prevalence
45%
Principal Component Analysis
9%
Probiotics
28%
Propofol
14%
Quality of Life
14%
Retrospective Study
14%
Selectin (Glycoprotein)
14%
Short Chain Fatty Acid
14%
Stomach Acid
28%
Stomach Antrum Vascular Ectasia
14%
Supplementation
14%
Survival Rate
14%
Tumor Cell
9%
Tumor Microenvironment
28%
Tumor Spheroid
14%
Upper Gastrointestinal Bleeding
19%
Urban Population
14%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Cancer
20%
Autoimmune Disease
5%
Cardiovascular Disease
14%
Cell Culture
14%
Coeliac Disease
14%
Colon Flora
14%
Colorectal Carcinoma
64%
Constipation
16%
Cyclin D1
14%
Digestive System Function Disorder
14%
Disease Exacerbation
7%
Diseases
31%
Gastroesophageal Reflux
14%
Gastrointestinal Disease
7%
Helicobacter Infection
15%
Helicobacter Pylori
38%
Infection
20%
Infection Rate
7%
Inflammation
5%
Inflammatory Arthritis
14%
Jejunum Ulcer
5%
Malignant Neoplasm
18%
Neoplasm
26%
Peptic Ulcer
5%
Prevalence
67%
Primary Culture
7%
Randomized Controlled Trial
7%
Retrospective Study
14%
Rheumatoid Arthritis
14%
Stomach Acid
14%
Stomach Antrum Vascular Ectasia
14%
Survival Rate
14%
Tumor Growth
7%
Tumor Microenvironment
28%
Virulence Factor
5%